Efficacy of pulsed intravenous immunoglobulin therapy in mixed connective tissue disease - 01/09/11
Doi : 10.1067/mjd.2001.118539
Abstract |
We describe a 69-year-old patient with long-standing mixed connective tissue disease who suffered from severe skin eruptions that did not respond to various immunosuppressive regimens. Therapy with high-dose intravenous immunoglobulin was successful in controlling the patient's disease without major side effects. We think that this regimen—although expensive—might be an interesting therapeutic option in selected patients with mixed connective tissue disease that is refractory to other treatment modalities. (J Am Acad Dermatol 2002;46:123-7.)
Le texte complet de cet article est disponible en PDF.Plan
 | Reprint requests: Professor G. Fierlbeck, MD, Universitäts-Hautklinik. Liebermeisterstr 25, D-72076 Tübingen, Germany. E-mail: gerhard.fierlbeck@med.uni-tuebingen.de. |
| Published online Oct 23, 2001. |
© 2001
American Academy of Dermatology, Inc. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 46 - N° 1
P. 123-127 - janvier 2002 Retour au numéro
Article précédent
- Cicatricial pemphigoid with circulating IgA and IgG autoantibodies to the central portion of the BP180 ectodomain: Beneficial effect of adjuvant therapy with high-dose intravenous immunoglobulin
- Martin Leverkus a, Matthias Georgi a, Zhuxiang Nie b, Takashi Hashimoto b, Eva-Bettina Bröcker a, Detlef Zillikens a
- Acral localized acquired cutis laxa associated with rheumatoid arthritis
- Franco Rongioletti, Maurizio Cutolo, Piera Bondavalli, Alfredo Rebora
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?